Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH trial)

被引：0
|
作者：
Coyle, V. [1 ]
Forde, C. [1 ]
Adams, R. [2 ]
Barnes, R. [3 ]
Chau, I. [4 ]
Clarke, M. [5 ]
Doran, A. [6 ]
Grayson, M. [7 ]
McAuley, D. [8 ]
McDowell, C. [6 ]
Phair, G.
Plummer, R. [9 ]
Thomas, A. [10 ]
Wilson, R. [11 ]
McMullan, R. [8 ]
机构：
[1] Queens Univ, Patrick G Johnston Ctr Canc Res, Belfast, Antrim, North Ireland
[2] Velindre Canc Ctr, Oncol, Cardiff, Wales
[3] Cardiff Univ, Sch Med, Cardiff, Wales
[4] Royal Marsden NHS Fdn Trust, Med, Sutton, Surrey, England
[5] Queens Univ, Northern Ireland Methodol Hub, Belfast, Antrim, North Ireland
[6] Belfast HSC Trust, Northern Ireland Clin Trials Unit, Belfast, Antrim, North Ireland
[7] Belfast HSC Trust, Northern Ireland Canc Res Consumer Forum, Belfast, Antrim, North Ireland
[8] Queens Univ, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland
[9] Freeman Rd Hosp, NHS Fdn Trust, Northern Ctr Canc Care, Sir Bobby Robson Canc Trials Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England
[10] Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England
[11] Beatson Canc Ctr, Med Oncol, Glasgow, Lanark, Scotland
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1676
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1704P
引用
收藏
页码：S1188 / S1188
页数：1
相关论文
共 50 条
  • [41] Therapy options for patients with low-risk prostate cancer. PREFERE trial
    Ohlmann, C. -H.
    Bottke, D.
    Stoeckle, M.
    Albers, P.
    Schmidberger, H.
    Haerter, C.
    Kristiansen, G.
    Bussar-Maatz, R.
    Wiegel, T.
    ONKOLOGE, 2015, 21 (09): : 787 - +
  • [42] Efficacy of an antimicrobial stewardship intervention for early adaptation of antibiotic therapy in high-risk neutropenic patients
    Durand, Claire
    Risso, Karine
    Loschi, Michael
    Retur, Nicolas
    Emery, Audrey
    Courjon, Johan
    Cluzeau, Thomas
    Carles, Michel
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2024, 13 (01)
  • [43] Efficacy of an antimicrobial stewardship intervention for early adaptation of antibiotic therapy in high-risk neutropenic patients
    Claire Durand
    Karine Risso
    Michael Loschi
    Nicolas Retur
    Audrey Emery
    Johan Courjon
    Thomas Cluzeau
    Michel Carles
    Antimicrobial Resistance & Infection Control, 13
  • [44] Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia:: A randomized controlled trial
    Castro-Guardiola, A
    Viejo-Rodríguez, AL
    Soler-Simon, S
    Armengou-Arxé, A
    Bisbe-Company, V
    Peñarroja-Matutano, G
    Bisbe-Company, J
    García-Bragado, F
    AMERICAN JOURNAL OF MEDICINE, 2001, 111 (05): : 367 - 374
  • [45] Early empiric antibiotic therapy for febrile neutropenia patients at low risk
    Rolston, KVI
    Rubenstein, EB
    Freifeld, A
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1996, 10 (02) : 223 - &
  • [46] Does home antibiotic therapy increase medical risk for patients with low-risk febrile neutropenia? A multi-institutional randomized trial.
    Talcott, JA
    Yeap, B
    Godley, PA
    Lu, C
    Siegel, RD
    Clark, JA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 757S - 757S
  • [47] Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients Comments
    Qiu, Mei
    Du, Lixin
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (05) : eL220501
  • [48] Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients In Response
    Joung, Boyoung
    Kim, Daehoon
    Yang, Pil-Sung
    Sung, Jung-Hoon
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (05)
  • [49] Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia
    Koh, A
    Pizzo, PA
    CANCER INVESTIGATION, 2002, 20 (03) : 420 - 433
  • [50] Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients: a pilot study in China
    He, Lixian
    Zhou, Caicun
    Zhao, Su
    Weng, Heng
    Yang, Guowang
    ANTI-CANCER DRUGS, 2015, 26 (03) : 359 - 362
12345